Several studies have shown that the NLRP3 inflammasome and caspase-1 are directly involved in NAFLD by promoting the development of inflammation and fibrosis and also indirectly by promoting associated metabolic disturbances such as adipose tissue inflammation and insulin resistance [6, 7, 10–12]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.